FITC Anti-Human CD47 Antibody[CC2C6D4]

Introducing the FITC Anti-Human CD47 Antibody [CC2C6D4], a cutting-edge product designed to revolutionize the field of immunology. This antibody, meticulously developed by our team of expert scientists, offers unparalleled specificity and sensitivity in detecting CD47, a crucial protein involved in various cellular processes.

The FITC Anti-Human CD47 Antibody [CC2C6D4] is conjugated with fluorescein isothiocyanate (FITC), a highly stable and bright fluorochrome, enabling precise visualization and analysis of CD47 expression in a multitude of experimental settings. Its exceptional binding affinity ensures accurate identification and quantification of CD47, facilitating comprehensive investigations into its functional roles and potential therapeutic applications.

This antibody has undergone rigorous quality control measures to guarantee optimal performance and reproducibility. Its exceptional specificity ensures minimal cross-reactivity with other antigens, ensuring reliable and precise results. Furthermore, its high sensitivity allows for the detection of even low levels of CD47 expression, enabling researchers to explore its presence in various cell types and tissues.

The FITC Anti-Human CD47 Antibody [CC2C6D4] is compatible with a wide range of techniques, including flow cytometry, immunofluorescence, and immunohistochemistry. Its versatility allows for seamless integration into diverse experimental workflows, facilitating comprehensive investigations into CD47's involvement in immune regulation, cancer biology, and beyond.

With its exceptional performance and reliability, the FITC Anti-Human CD47 Antibody [CC2C6D4] is an invaluable tool for researchers seeking to unravel the intricate mechanisms underlying CD47-mediated processes. Unlock the potential of CD47 research with this state-of-the-art antibody, and pave the way for groundbreaking discoveries in the field of immunology.